Summary The human papillomavirus has emerged over the past decade as the leading candidate to be the sexually transmitted aetiological factor in cervical cancer. Although it appears that papillomavirus types 16 and 18 are associated with a higher risk of advanced cervical neoplasia, most of the evidence comes from studies which do not satisfy basic epidemiological requirements, and are therefore difficult to interpret. The most significant problems are the small sample size, potentially biased selection of study subjects, the difficulties in cytologically distinguishing precancerous lesions from papilloma infection of the cervix, the unknown specificity and sensitivity of the various hybridisation methods for determining papillomavirus infection status, and the statistical analyses and presentation of results. On the basis of the existing studies, one is forced to conclude that, while experimental data suggest an oncogenic potential for HPV, the epidemiological evidence implicating it as a cause of cervical neoplasia is still rather limited.
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Independently of her age, a woman's risk of cervical cancer is strongly associated with various measures of sexual activity, and specifically the number of partners, and age at first intercourse (Brinton and Fraumeni, 1986) . The independent effect of the number of partners, and the increased risk for women whose husbands reported multiple sexual partners (Buckley et al., 1981; Harris et al., 1980; Reeves et al., 1985; Zunzunegui et al., 1986 ) strongly suggests the role of a sexually transmitted infectious agent, although other factors, such as oral contraceptive use and smoking may also be important (Harris et al., 1980; Winkelstein et al., 1984) . For over twenty years, much attention was focused on herpes simplex type 2, but its role in cervical neoplasia has never been adequately confirmed (Armstrong et al., 1986) or refuted (Vonka et al., 1984) . The currently favoured hypothesis is that certain types of human papillomavirus (HPV) play a key aetiological role (Howley, 1986) .
Although this hypothesis emerged thirteen years ago (zur Hausen et al., 1974) and has been supported by experimental data, it has been difficult to test it epidemiologically because of the problems in assessing HPV exposure. It has neither been possible to grow the virus in vitro, nor to develop a reliable serological test for its antigens. HPV infection was therefore initially assessed using clinical criteria, supplemented by colposcopy, cytology and histopathology. Electron microscopy and immunoperoxidase staining of the HPV capsid antigen provided more specific means of detecting the virus in active infections, but it was not until the cloning of HPV-DNA in bacteria and the application of DNA hybridisation methods that the large variety of HPV types (today close to 50) was recognized, and a means of assessing type-specific infection became available, as reviewed by McDougall et al., (1986) . Types 6 and 11 have since been associated with benign lesions (condylomas) or low grade dysplasia while types 16 and 18 have been linked to cervical cancer (Crawford, 1983; Howley, 1986) . HPV types 31, 33 and 35 have been reported in only a few case-series.
Some doubt has recently been cast on the role of the virus in cervix cancer by reports of high prevalence of HPV 16 and 18 in normal cervical tissue (Cox et al., 1986; Macnab et al., 1986; Meanwell et al., 1987; Reeves et al., 1987; , and the possibility that the apparent association with cervical neoplasia disappears after age-adjustment (Meanwell et al., 1987) . In the light of the continuing debate about the importance of HPV infection in the aetiology of cervical cancer (Editorial, 1987a,b; Mufioz & Bosch, 1987) and confronted by practical problems in the design of our own epidemiological study, we decided to critically evaluate the available epidemiological evidence, which consists of prevalence surveys of HPV in various population groups, and some cohort studies of women with cervical HPV infection or low-grade dysplasia. This paper does not consider the large body of experimental evidence, which has been reviewed elsewhere (Pfister, 1987; Hausen & Schneider, 1987) . analyzed only in one of these studies (Lorincz et al., 1986) , and 33 and 35 in no studies. The table gives the number of subjects tested in each cervical lesion group (invasive carcinoma, cervical intraepithelial neoplasia, referred to as CIN, or normal), and the percentage positive for various types of HPV in each group. In five of these studies, HPV prevalence rates are given separately for the three degrees of CIN (Lorincz et al., 1986; McCance et al., 1985; Schneider et al., 1985; Schneider et al., 1987; Wagner et al., 1984) . The initial impression is that within each study women with cervical neoplasia have HPV DNA of types 16 and 18 detectable in their cervical cells more frequently than women with normal cervices, that the prevalence rates increase with the severity of the lesion, and that there is a considerable variation in prevalence within each lesion group, although most of the studies are based on small numbers and different hybridisation techniques have been used. Types 6 and 11 are seldom found in cervical cancer but appear to be more frequent in CIN lesions than in the normal cervix. Although these studies could technically be viewed as case-control studies, they were not planned as full epidemiological investigations, and none of them satisfy the usual criteria of design and analysis which would ensure the elimination of bias, confounding and chance in their interpretation.
HPV prevalence surveys
Correspondence: N. Mufioz. studies in which the histology or cytology of the lesion was specified and DNA aUnless otherwise noted, figures are for type 16 only; bType 18 only; cTypes 16 and 18 combined; dTwo control groups were used, one for women with inflammatory cervical lesions, the other of women with normal cervical cytology; eTwo control groups were used, one from a venereal disease clinic and the other from a family planning clinic. 'Durst et al., 1983; 2Boshart et al., 1984; 3De Villiers et al., 1986; 4Wagner et al., 1984;  'Schneider et al., 1985; 6Schneider et al., 1987; 7Scholl et al., 1985; 8McCance et al., 1985; 9Meanwell et al., 1987; I'Toon et al., 1986;  ' 'Wickenden et al., 1985; '2Cox et al., 1986; '3Lorincz et al., 1986; '4Fukushima et al., 1985; "Crum et al., 1986; '6Prakash et al., 1985; 17Reeves et al., 1987;  '8Reeves (pers. comm).); '9McCance et al., 1986; 2 'Yoshikawa et al., 1985. Nevertheless, they still contribute the main body of epidemiological evidence in support of the HPV/cervical cancer relationship. It is therefore important to understand their shortcomings in some detail.
Source of cases and controls Some of the studies do not include controls or do not describe the source of case and control material sufficiently clearly to enable the evaluation of any selection biases (Boshart et al., 1984; Crum et al., 1986; De Villiers et al., 1986; Durst et al., 1983; Fukushima et al., 1985; Yoshikawa et al., 1985) . In some papers which do, the subjects come from a limited number of clinics or hospitals, but it is still not clear whether any further selection has taken place (Cox et al., 1986; Lorincz et al., 1986; Macnab et al., 1986; Meanwell et al., 1987; Schneider et al., 1987; Scholl et al., 1985; Wagner et al., 1984; Wickenden et al., 1985) . Information on the source of cases is important in the choice of the control group. If case and control HPV DNA prevalence rates are to be used to estimate the relative risk of HPV infection in causing cervical neoplasia, the controls must be a representative sample of the population which gave rise to the cases. For example, if cases are drawn from a radiotherapy clinic and controls from a series of women with benign gynaecological disorders (Meanwell et al., 1987) , it is possible that the two series differ substantially in terms of sexual behaviour, social class or other factors which influence HPV infection rates.
Lack of information on source population also makes comparisons of prevalence between studies very difficult.
Definition of cases and controls
In studies of HPV in cervical carcinomas, there is little ambiguity about what constitutes a case. However, in studies of CIN, the definition of a case is generally based on cytological and histological criteria, and it can be difficult to distinguish, on morphological grounds only, CIN from the subclinical HPV infection sometimes referred to as 'flat and atypical condylomas' (Koss, 1987) . A number of studies have reported high rates of reclassification from CINI to HPV infection using recently developed cytological criteria, which may also reflect a high prevalence of mixed CIN/HPV lesions (Meisels et al., 1982 (Meisels et al., , 1983 (Crum et al., 1986; Schneider et al., 1987; Wagner et al., 1984 (Meanwell et al., 1987) , and only two others even mention the mean age of cases and controls (McCance et al., 1985; Toon et al., 1986) .
Cohort studies
There have been a number of studies published to date in which HPV infection is assessed in women with some cervical abnormality, who are then followed up for the occurrence of advanced CIN lesions. These studies are certainly based on sounder epidemiological ground than the prevalence surveys, but they share one major deficiency: they only involve the follow-up of women with some degree of cervical abnormality, whether CINI or cytologically detected HPV infection, and a control group of women with cytologically normal cervices is not followed up in a similar way.
Some of them, however, do use internal controls, comparing the progression rate in women infected with HPV types assumed to have low malignant potential (HPV 6 or I1) with those in women infected with types suspected to have high malignant potential (HPV 16 or 18).
Several studies made an initial classification of HPV infection based on cytology alone (De Brux et al., 1983; Meisels & Morin, 1986; Mitchell et al., 1986; Nash et al., 1987) . If the presence of HPV is not initially confirmed by DNA hybridisation, one might be following up a certain number of women who already have CIN not associated with HPV, because of the difficulties in cytologically distinguishing the two conditions (Koss, 1987; Meisels et al., 1983) . One of the studies used population expected rates of carcinoma in situ for comparison (Mitchell et al., 1986 ).
Since women with cervical abnormalities are likely to have had more subsequent smears than those in the comparison group which includes a proportion of women who do not undergo regular screening, the observed excess may be in part due to underdiagnosis in the latter.
Three studies assess HPV exposure on the basis of typespecific DNA hybridisation (Campion et al., 1986; Schneider et al., 1987; Syrjanen et al., 1986 The third study is again of women with cytological abnormalities . A group of women with a cytological diagnosis of CIN or condyloma were followed up for progression to higher grade CIN or cancer. Five out of 24 women in whom only HPV 16/18 was detected progressed to CINIII, as compared with none of 12 women positive for HPV 6/11 alone.
Discussion
Whereas there is an impressive body of experimental evidence suggesting an oncogenic potential for certain HPV types, no epidemiological study has convincingly demonstrated that HPV causes cervical cancer. The ideal study of the relationship between HPV and cervical cancer would be one in which a large unselected group of women was examined for HPV infection and other potential risk factors, and then followed up for the occurrence of cervical cancer. Apart from the expense of such a study, and the length of time which would need to elapse for sufficient cases to occur, this Note added in proof After submission of this paper, a report was published which describes the largest series of cervical cytological samples so far analyzed for the presence of HPV DNA. Although the prevalence is clearly higher in women with cervical lesions than in those without, the study suggests that the filter in situ hybridisation test is much less sensitive than the Southern blot. The study also reports a decrease with age of the prevalence of HPV DNA positivity for types 6/11 and 16/18 combined in women with a normal cytology; there was, however, no change with age of this prevalence in women with cytological diagnosis of CIN or invasive cancer (de Villiers et al., 1987) .
